11.94

2.05% -0.25

After Hours: 11.94

Olema Pharmaceuticals Inc (OLMA)

Overview News Price History Option Chain Financials Discussions Forecast

Olema Pharmaceuticals Inc stock is traded at $11.94, with a volume of 239.35K. It is down -2.05% in the last 24 hours and up +1.19% over the past month. Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Previous Close:

$12.19

Open:

$12.19

24h Volume:

239.35K

Relative Volume:

0.38

Market Cap:

$687.20M

Revenue:

Net Income/Loss:

$-96.66M

P/E Ratio:

-4.9544

EPS:

-2.41

Net Cash Flow:

$-83.73M

1W Performance:

-8.01%

1M Performance:

+1.19%

6M Performance:

+5.48%

1Y Performance:

-3.32%

1-Day Range:

$11.79

$12.46

1-Week Range:

$11.79

$13.28

52-Week Range:

$8.51

$17.79

Olema Pharmaceuticals Inc Stock (OLMA) Company Profile

Name

Olema Pharmaceuticals Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

(415) 651-3316

Address

780 BRANNAN STREET, SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2024-08-06

Latest SEC Filings

OLMA's Discussions on Twitter

Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-24	Initiated	Citigroup	Buy
Jul-21-23	Initiated	Oppenheimer	Outperform
May-05-23	Initiated	CapitalOne	Overweight
Feb-22-23	Initiated	Credit Suisse	Outperform
Jul-06-22	Resumed	Canaccord Genuity	Buy
Jun-09-22	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-28-22	Initiated	H.C. Wainwright	Neutral
Dec-07-21	Resumed	Cowen	Outperform
Dec-14-20	Initiated	Canaccord Genuity	Buy
Dec-14-20	Initiated	Cowen	Outperform
Dec-14-20	Initiated	JP Morgan	Overweight
Dec-14-20	Initiated	Jefferies	Buy

View All

Olema Pharmaceuticals Inc Stock (OLMA) Latest News

Sep 25, 2024

Affinity Asset Advisors LLC Purchases Shares of 275,000 Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Sep 25, 2024

Affinity Asset Advisors LLC Invests $2.98 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Sep 25, 2024

Rhumbline Advisers Buys 17,953 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Sep 25, 2024

Sep 24, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Logos Global Management LP - Defense World

Sep 24, 2024

Great Point Partners LLC Takes Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Sep 24, 2024

Great Point Partners LLC Purchases New Stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Sep 24, 2024

Sep 23, 2024

Examining the Potential Price Growth of Olema Pharmaceuticals Inc (OLMA) - Knox Daily

Sep 23, 2024

Sep 21, 2024

A Tale of Resilience: Olema Pharmaceuticals Inc Amid Stock Market Turbulence - The InvestChronicle

Sep 19, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Position Boosted by Bank of New York Mellon Corp - MarketBeat

Sep 19, 2024

Bank of New York Mellon Corp Acquires 58,622 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Sep 19, 2024

Sep 18, 2024

Market Insight: Olema Pharmaceuticals Inc (OLMA)’s Notable Gain, Closing at 12.27 - The Dwinnex

Sep 18, 2024

Olema Pharmaceuticals Inc’s results are impressive - US Post News

Sep 18, 2024

Sep 16, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Purchased by Victory Capital Management Inc. - Defense World

Sep 16, 2024

Victory Capital Management Inc. Has $8.38 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Sep 16, 2024

Sep 13, 2024

Analysts Set Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Target Price at $27.00 - MarketBeat

Sep 13, 2024

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Sep 13, 2024

Sep 11, 2024

Goldman initates Olema Pharmaceuticals Inc (OLMA) rating to a Buy - Knox Daily

Sep 11, 2024

Sep 10, 2024

Goldman Sachs maintains Buy rating on Olema Pharma shares with consistent target - Investing.com Canada

Sep 10, 2024

Sep 09, 2024

The Potential Rise in the Price of Olema Pharmaceuticals Inc (OLMA) following insiders activity - Knox Daily

Sep 09, 2024

Are Olema Pharmaceuticals Inc (OLMA) shares a good deal now? - US Post News

Sep 09, 2024

Candriam S.C.A. Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat

Sep 09, 2024

Candriam S.C.A. Has $11.45 Million Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World

Sep 09, 2024

Sep 05, 2024

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 6.8% Higher - MarketBeat

Sep 05, 2024

Where are the Opportunities in (OLMA) - Stock Traders Daily

Sep 05, 2024

Selling Buzz: Olema Pharmaceuticals Inc [OLMA] 10% Owner Paradigm Biocapital Advisors L sells 2,400,000 shares of the company – Knox Daily - Knox Daily

Sep 05, 2024

Sep 04, 2024

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sep 04, 2024

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Sep 04, 2024

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Sep 04, 2024

Sep 02, 2024